| Literature DB >> 32365793 |
Mirela L Moldovan1, Rahela Carpa2, Ionel Fizeșan3, Laurian Vlase4, Cătălina Bogdan1, Sonia M Iurian4, Daniela Benedec5, Anca Pop3.
Abstract
Winery industry by-products have a great reuse potential in the pharmaceutical and cosmetic fields due to their bioactive compounds. This study investigates the phytochemical profile and the bioactivity of Vitis vinifera variety Fetească neagră tendrils extract (TE) and leaves extract (LE), intended to be used in oral hygiene products recommended in periodontal disease. The evaluation of the phenolic content was performed by colorimetric analysis. Liquid chromatography coupled with mass spectrometry was used to determine the chemical profile of the two extracts obtained from V. vinifera. Moreover, the antioxidant activity of the extracts was determined by spectrophotometric methods, as well as on human gingival fibroblasts (HGF) cell line. The cytocompatibility and cytoprotective effect against nicotine-induced cytotoxicity were tested, as well as the anti-inflammatory and antimicrobial effects. The TE showed higher total polyphenolic content, rich in rutin, compared to the leaves extract that displayed important amounts of isoquercitrin. The antioxidant effect was confirmed by both non-cellular and cellular tests. The cytocompatibility of the extracts was confirmed at a wide range of concentrations. The cytoprotective effect was demonstrated in HGF exposed to cytotoxic doses of nicotine; 300 µg/mL of both tested extracts decreased nicotine toxicity by approximately 20%. When challenged with E. coli polysaccharides, in HGF cells co-exposed to TE and LE, a reduction in the release of proinflammatory cytokines (IL-8, IL-6 and IL-1β) was observed. The extracts were both able to reduce the levels of reactive oxygen species and inflammatory cytokines, and had notable antimicrobial effects on pathogenic bacteria associated with periodontitis.Entities:
Keywords: Vitis vinifera; anti-inflammatory; antimicrobial; antioxidant; cytocompatibility; extract; tendrils
Year: 2020 PMID: 32365793 PMCID: PMC7278858 DOI: 10.3390/antiox9050373
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Total phenolic contents and antioxidant activity of V. vinifera Fn LE and TE.
| Samples | TFC (mg RE/g) | Caffeic Acid Derivatives (mg CAE/g) | TPC (mg GAE/g) | IC50 (DPPH) (mg/mL) | FRAP (µmol Te/mL) |
|---|---|---|---|---|---|
| TE | 14.21 ± 0.20 a | 4.14 ± 0.07 a | 35.65 ± 0.33 a | 0.155 ± 0.04 b,c | 10.60 ± 0.39 a |
| LE | 16.75 ± 0.12 | 6.39 ± 1.11 | 28.62 ± 0.24 | 0.248 ± 0.01 a | 6.29 ± 0.20 |
| Trolox | - | - | - | 0.011 ± 0.00 | - |
Legend: Fn: Feteasca neagra; TFC: total flavonoid content; TPC: Total polyphenols content; CAE: caffeic acid equivalents GAE: gallic acid equivalents; RE: rutin equivalents; Te: Trolox equivalents. Values (mean ± SD, n = 3) marked with uncapitalized letters showed statistical differences: a p < 0.001 (LE versus TE; LE versus Trolox); b p < 0.05 (LE versus TE); c 0.001 < p < 0.05 (TE versus Trolox).
Polyphenols identified in V. vinifera LE and TE by liquid chromatography coupled with mass spectrometry in tandem (LC-MS/MS) (µg/g plant material).
| Polyphenolic Compounds | tR ± SD (min) | LE (µg/g) | TE (µg/g) | |
|---|---|---|---|---|
| Gallic acid | 169 | 1.50 ± 0.01 | 5.50 ± 0.05 | 6.90 ± 0.11 a |
| Protocatechuic acid | 153 | 2.80 ± 0.01 | 1.71 ± 0.02 | 7.92 ± 0.08 a |
| Caftaric acid | 311 | 3.54 ± 0.05 | < 0.02 | <0.02 |
| Catechin | 289 | 6.00 ± 0.03 | 23.31 ± 0.36 | 51.72 ± 1.06 a |
| Epicatechin | 289 | 9.00 ± 0.01 | 7.10 ± 0.09 | 2.60 ± 0.09 a |
| Hyperoside | 463 | 18.60 ± 0.12 | 147.09 ± 1.79 | 127.39 ± 2.61 a |
| Isoquercitrin | 463 | 19.60 ± 0.10 | 903.49 ± 6.51 | 541.34 ± 6.44 a |
| Rutin | 609 | 20.20 ± 0.15 | 385.63 ± 3.36 | 617.21 ± 6.79 a |
| Quercitrin | 447 | 23.64 ± 0.13 | 188.74 ± 2.26 | 100.87 ± 2.13 a |
| Quercetin | 301 | 26.80 ± 0.15 | 10.54 ± 0.24 | 8.89 ± 0.11 a |
Note: Each value is the mean ± SD of three independent measurements. a p < < 0.001 (LE versus TE).
Figure 1Cytocompatibility of the LE (A) and TE (B) observed using Alamar Blue assay on human gingival fibroblasts (HGF). The results are expressed as relative means ± standard deviations (six technical replicates for each of the three biological replicates) where the negative control (DMSO 0.2%) is 100%.
Figure 2Cytoprotective effect of LE and TE against nicotine-induced cytotoxicity was analyzed after a 24 h post-exposure to three concentrations of the LE and TE in combination with 10 μM nicotine using AB assay. The values are expressed as mean ± standard deviation (SD) of three biological replicates. Different letters (a–c) represent the significant differences in mean cellular viability (ANOVA + Holm-Sidak post hoc test at p < 0.05 level of significance).
Figure 3Antioxidant effect of the LE (A) and TE (B) evaluated using DCFH-DA assay on HGF cells. The cellular model was pre-exposed to LE and TE (100, 200, and 300 µg/mL) or NAC (20 mM) for 24 h, and further incubated with 50 µM DCFH-DA. The antioxidant effect was evaluated after 2 h on stimulated (250 µM H2O2) and un-stimulated conditions. The results are expressed as relative means ± standard deviations (six technical replicates for each of the three biological replicates) where the negative control (DMSO 0.2%) is 100%. Different letters (a–e refers to comparisons on non-stimulated conditions, whereas A–E refers to comparisons on stimulated conditions) represent significant differences (ANOVA + Holm-Sidak post hoc test at p < 0.05 level of significance).
Figure 4The extracellular release of proinflammatory cytokines IL-8 (A), IL- 6 (B), and IL-1β (C) was analyzed in cell-free supernatants by ELISA at 24 h post-exposure to three concentrations of the LE and TE in combination with 100 ng/mL LPS. The values are expressed as mean ± standard deviation (SD) of four biological replicates. Different letters (a–e) represent the significant differences in mean quantities of cytokines measured (ANOVA + Holm-Sidak post hoc test at p < 0.05 level of significance).
The diameter of inhibition zone (mm).
| Bacterial/Fungal Strain | Inhibition Diameter for the Tested Samples (mm) ± SD | ||
|---|---|---|---|
| C | 1 | 2 | |
| 0 ± 0.00 | 10 ± 0.00 | 13 ± 1.41 | |
| 0 ± 0.00 | 10 ± 0.00 | 12 ± 1.41 | |
| 0 ± 0.00 | 10 ± 0.00 | 11.5 ± 0.71 | |
| 0 ± 0.00 | 14.5 ± 0.71 | 12 ± 1.41 | |
| 0 ± 0.00 | 10 ± 1.41 | 11.5 ± 0.71 | |
| 0 ± 0.00 | 0 ± 0.00 | 0 ± 0.00 | |
| 0 ± 0.00 | 0 ± 0.00 | 0 ± 0.00 | |
Legend: 1 = TE; 2 = LE; C—ethyl alcohol/H2O 50/50 (v/v).